Roivant Sciences Ltd.
US ˙ NasdaqGS ˙ BMG762791017

SecurityROIV / Roivant Sciences Ltd.
InsiderMatthew Gline
This page shows the track record and history of Gline Matthew insider trades in Roivant Sciences Ltd.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Matthew Gline in ROIV / Roivant Sciences Ltd.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-09-18 3,315 15.0700 3,315 15.0700 49,957 0 15.0900 66 0.13

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ROIV / Roivant Sciences Ltd. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Matthew Gline in ROIV / Roivant Sciences Ltd.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-09-23 1,983,257 11.7900 1,983,257 11.7900 23,382,600 197 9.0800 -5,374,626 -22.99
2022-05-20 139,791 3.7000 139,791 3.7000 517,227

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ROIV / Roivant Sciences Ltd. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-18 2025-09-18 4 Gline Matthew ROIV Common Shares P - Purchase D 15.0700 3,315 50 17,287,081
2025-05-22 2025-05-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.0400 -10,945 -121 17,283,766
2025-04-22 2025-04-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.1500 -10,945 -111 17,294,711
2025-03-24 2025-03-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.9700 -10,945 -120 17,305,656
2025-02-24 2025-02-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.7200 -10,945 -117 17,316,601
2025-01-22 2025-01-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.1500 -11,623 -130 17,327,546
2024-12-26 2024-12-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.5700 -10,945 -127 17,339,169
2024-11-22 2024-11-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.4900 -10,945 -126 17,350,114
2024-10-22 2024-10-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.9200 -10,945 -130 17,361,059
2024-09-24 2024-09-23 4 Gline Matthew ROIV Common Shares J - Other D 11.9700 -498,539 -5,968 17,372,004
2024-09-24 2024-09-23 4 Gline Matthew ROIV Common Shares S - Sale D 11.7900 -1,983,257 -23,383 17,870,543
2024-09-24 2024-09-23 4 Gline Matthew ROIV Common Shares M - Exercise D 3.8500 1,550,000 5,968 19,853,800
2024-09-24 2024-09-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.9700 -10,945 -131 18,303,800
2024-08-22 2024-08-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.4800 -10,947 -126 18,314,745
2024-07-30 2024-07-26 4 Gline Matthew ROIV Common Shares A - Award D 14,450,000 18,325,692
2024-07-30 2024-07-26 4 Gline Matthew ROIV Common Shares A - Award D 2,754,821 3,875,692
2024-07-25 2024-07-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.0000 -10,945 -120 1,120,871
2024-06-24 2024-06-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.8000 -10,945 -118 1,131,816
2024-05-22 2024-05-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.3700 -10,945 -124 1,142,761
2024-04-23 2024-04-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.4600 -10,945 -114 1,153,706
2024-04-02 2024-03-30 4 Gline Matthew ROIV Common Shares F - Taxes D 10.5400 -215,991 -2,277 1,164,651
2024-04-02 2024-03-30 4 Gline Matthew ROIV Common Shares M - Exercise D 390,579 1,380,642
2024-03-22 2024-03-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.0100 -10,945 -110 990,063
2024-02-22 2024-02-20 4 Gline Matthew ROIV Common Shares F - Taxes D 11.5400 -10,945 -126 1,001,008
2024-01-23 2024-01-20 4 Gline Matthew ROIV Common Shares F - Taxes D 10.3500 -10,945 -113 1,011,953
2023-12-29 2023-12-27 4 Gline Matthew ROIV Common Shares F - Taxes D 11.5800 -22,043 -255 1,022,898
2023-12-29 2023-12-27 4 Gline Matthew ROIV Common Shares M - Exercise D 38,453 1,044,941
2023-12-22 2023-12-20 4 Gline Matthew ROIV Common Shares F - Taxes D 9.9600 -10,945 -109 1,006,488
2023-11-27 2023-11-22 4 Gline Matthew ROIV Common Shares J - Other D 8.6800 -11,318 -98 1,017,433
2023-10-26 2023-10-24 4 Gline Matthew ROIV Common Shares J - Other D 8.9900 -12,489 -112 1,028,751
2023-09-29 2023-09-28 4 Gline Matthew ROIV Common Shares J - Other D 12.6700 -10,243 -130 1,041,240
2023-09-29 2023-09-27 4 Gline Matthew ROIV Common Shares M - Exercise D 17,762 1,051,483
2023-09-26 2023-09-22 4 Gline Matthew ROIV Common Shares J - Other D 10.1900 -11,227 -114 1,033,721
2023-08-29 2023-08-28 4 Gline Matthew ROIV Common Shares J - Other D 11.2500 -6,784 -76 1,044,948
2023-08-29 2023-08-27 4 Gline Matthew ROIV Common Shares M - Exercise D 12,088 1,051,732
2023-08-24 2023-08-22 4 Gline Matthew ROIV Common Shares J - Other D 10.8300 -11,015 -119 1,039,644
2023-08-03 2023-08-02 4 Gline Matthew ROIV Common Shares J - Other D 11.7900 -11,749 -139 1,050,659
2023-07-31 2023-07-27 4 Gline Matthew ROIV Common Shares M - Exercise D 23,149 1,062,408
2023-07-26 2023-07-24 4 Gline Matthew ROIV Common Shares J - Other D 10.9900 -11,146 -122 1,039,259
2023-06-26 2023-06-22 4 Gline Matthew ROIV Common Shares J - Other D 10.0100 -10,863 -109 1,050,405
2023-05-31 2023-05-31 4 Gline Matthew ROIV Common Shares J - Other D 9.0900 -30,266 -275 1,061,268
2023-05-31 2023-05-27 4 Gline Matthew ROIV Common Shares M - Exercise D 53,281 1,091,534
2023-05-25 2023-05-23 4 Gline Matthew ROIV Common Shares J - Other D 9.5800 -18,972 -182 1,038,253
2023-04-24 2023-04-20 4 Gline Matthew ROIV Common Shares F - Taxes D 8.8000 -19,375 -170 1,057,225
2023-03-27 2023-03-23 4 Gline Matthew ROIV Common Shares J - Other D 7.3000 -18,563 -136 1,076,600
2023-02-24 2023-02-22 4 Gline Matthew ROIV Common Shares J - Other D 8.4300 -14,471 -122 1,095,163
2023-01-26 2023-01-24 4 Gline Matthew ROIV Common Shares J - Other D 8.5600 -15,594 -133 1,109,634
2022-12-28 2022-12-23 4 Gline Matthew ROIV Common Shares J - Other D 7.1000 -19,408 -138 1,125,228
2022-11-22 2022-11-20 4 Gline Matthew ROIV Common Shares J - Other D 5.0000 -19,373 -97 1,144,636
2022-10-27 2022-10-25 4 Gline Matthew ROIV Common Shares S - Sale D 4.4000 -19,276 -85 1,164,009
2022-09-27 2022-09-23 4 Gline Matthew ROIV Common Shares S - Sale D 3.0700 -21,053 -65 1,183,285
2022-08-26 2022-08-24 4 Gline Matthew ROIV Common Shares S - Sale D 3.7100 -20,009 -74 1,204,338
2022-07-27 2022-07-25 4 Gline Matthew ROIV Common Shares S - Sale D 4.3300 -20,455 -89 1,224,347
2022-06-27 2022-06-23 4 Gline Matthew ROIV Common Shares S - Sale D 4.3400 -19,855 -86 1,244,802
2022-05-24 2022-05-20 4 Gline Matthew ROIV Common Shares S - Sale D 3.7000 -139,791 -517 1,264,657
2022-04-27 2022-04-25 4 Gline Matthew ROIV Common Shares S - Sale D 3.8400 -8,509 -33 1,404,448
2022-04-22 2022-04-20 4 Gline Matthew ROIV Stock Option (Right to Buy) A - Award D 3.85 16,523,184 16,523,184
2022-04-01 2022-03-30 4 Gline Matthew ROIV Common Shares F - Taxes D 4.7400 -25,254 -120 1,412,957
2022-04-01 2022-03-30 4 Gline Matthew ROIV Common Shares S - Sale D 4.8400 -33,686 -163 1,438,211
2022-03-29 2022-03-25 4 Gline Matthew ROIV Common Shares S - Sale D 5.0600 -35,386 -179 1,471,897
2022-03-22 2022-03-18 4 Gline Matthew ROIV Common Shares S - Sale D 5.1300 -82,006 -421 1,507,283
2022-03-09 2022-03-07 4 Gline Matthew ROIV Common Shares S - Sale D 5.5200 -92,324 -510 1,589,289
2021-10-01 3 Gline Matthew ROIV Common Shares D 1,681,613
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)